Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
e39 peptide vaccine (1 trial)
Carcinoma, Ovarian Epithelial (Phase 2)
Endometrial Neoplasms (Phase 2)
Ovarian Neoplasms (Phase 2)
Trials (1 total)
Trial APIs (1 total)